Search Results - "Hope, K.D."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Cardiogenic Shock in Children: Clinical Presentation and Outcomes by Puri, K., Denfield, S.W., Spinner, J.A., Hope, K.D., Tunuguntla, H.P., Choudhry, S., Dreyer, W.J., Price, J.F.

    “…Descriptive and outcomes data for cardiogenic shock (CS) are lacking in children. We present our findings of CS in a large cohort of children hospitalized with…”
    Get full text
    Journal Article
  2. 2

    External Evaluation of a Single Center Precision Tacrolimus Dosing Model for Pediatric Heart Transplant by Rower, J.E., Hong, B., Daly, K.P., Hope, K.D., Cabrera, A.G., Molina, K.M.

    “…Extensive variability in tacrolimus pharmacokinetics (PK) influences attainment of therapeutic immunosuppression following pediatric heart transplant…”
    Get full text
    Journal Article
  3. 3

    Intracardiac Thrombus Following Pediatric Heart Transplant: New Heart, New Problem? by Kaushal, S., Sachdeva, S., Caldarone, C., Choudhry, S., Hope, K.D., Tunuguntla, H.P., Spinner, J.A.

    “…Development of an intracardiac thrombus (IT) has been reported following pediatric heart transplantation (HT), however the incidence and risk factors are…”
    Get full text
    Journal Article
  4. 4

    Giant Coronary Aneurysms After Pediatric Heart Transplant: Giant Problem by Lynn, M.M., Hope, K.D., Puri, K., Spinner, J.A., Choudhry, S., Tunuguntla, H.P., Price, J.F., Denfield, S.W., Dreyer, W.J.

    “…Cardiac allograft vasculopathy (CAV) is a leading cause of death and retransplant after heart transplantation (HTx). Coronary aneurysms are not typically seen…”
    Get full text
    Journal Article
  5. 5

    One Heart, Two Problems: Cardiomyopathy and CPVT Secondary to RYR2 Mutation by Kaushal, S., Miyake, C.Y., Puri, K., Choudhry, S., Spinner, J., Tunuguntla, H., Price, J.F., Denfield, S.W., Dreyer, W.J., Hope, K.D.

    “…RYR2 mutations are known to cause catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited disorder with risk for life threatening atrial…”
    Get full text
    Journal Article
  6. 6

    Bacteriophage Therapy for Treatment of a Multi-Drug Resistant VAD-Specific Infection in a Pediatric Patient by Hope, K.D., Tunuguntla, H.P., Puri, K., Spinner, J.A., Choudhry, S., Price, J.F., Denfield, S.W., Dreyer, W.J., Adachi, I., Bocchini, C.E.

    “…Ventricular assist device (VAD) driveline infections are a source of significant morbidity and recurrence can result in multi-drug resistant infections…”
    Get full text
    Journal Article
  7. 7

    New Heart, Old Problems: Aortopulmonary Collaterals Cause Diastolic Heart Failure in a Pediatric Heart Transplant Recipient by Tadros, H.J., Qureshi, A.M., Puri, K., Tunuguntla, H.P., Denfield, S., Hope, K.D., Choudhry, S., Price, J.F., Adachi, I., Dreyer, W.J., Spinner, J.A.

    “…Aortopulmonary collaterals (APCs) frequently develop in children with single ventricle (SV) physiology. The prevalence and clinical impact of APCs after…”
    Get full text
    Journal Article
  8. 8

    Use of Donor Hearts with Low Ejection Fraction in Pediatric Heart Transplantation: A PHTS Analysis by Gupta, D., Cantor, R., Zhao, H., Clifford, S.A., Bansal, N., Hope, K.D., Albers, E., Prada-Ruiz, A., Reinhardt, Z., Sorabella, R.A., Kirklin, J.K., Ramakrishnan, K.V.

    “…Despite a growing number of children awaiting heart transplant (HT), annual number of HT is relatively unchanged and waitlist mortality is high especially in…”
    Get full text
    Journal Article
  9. 9

    AT1R-Ab: A New Player in Pediatric Heart Transplant AMR? by Spinner, J.A., Philogene, M., Nicholas, S., Jindra, P., Choudhry, S., Hope, K.D., Puri, K., Tunuguntla, H.P., Price, J., Denfield, S.W., Dreyer, W.J.

    “…Angiotensin II type 1 receptor antibodies (AT1R-Ab) are associated with non-human leukocyte antigen (HLA) mediated antibody mediated rejection (AMR) and graft…”
    Get full text
    Journal Article
  10. 10

    Location, Location, Location - Does Epitope Matching Matter in Pediatric Heart Transplantation? by Spinner, J.A., Ram, A.V., Magana, J., Nicholas, S., Dreyer, W.J., Hope, K.D., Choudhry, S., Puri, K., Tunuguntla, H., Price, J., Denfield, S.W., Jindra, P.T.

    “…Recent data in adult solid organ transplantation suggest that epitope-based human leukocyte antigen (HLA) matching may permit better risk assessment of de novo…”
    Get full text
    Journal Article
  11. 11

    Atypical Infiltrates on Endomyocardial Biopsy are Associated with Adverse Outcomes in Pediatric Heart Transplantation by Hope, K.D., Morris, S.A., Choudhry, S., Puri, K., Spinner, J.A., Tunuguntla, H.P., Price, J.F., Dreyer, W.J., Nicholas, S.K., Kearney, D.L., Denfield, S.W.

    “…The significance of atypical infiltrates, defined as eosinophils or plasma cells on endomyocardial biopsy (EMB) after pediatric heart transplant (HTx) is not…”
    Get full text
    Journal Article
  12. 12

    Combined Pediatric Heart-Liver Transplant Outcomes in the US: A 25 Year National Cohort Study by Choudhry, S., Dreyer, W.J., Wang, Y., Cabrera, A.G., Hope, K.D., Price, J.F., Spinner, J.A., Tunuguntla, H.P., Denfield, S.W.

    “…Pediatric combined heart-liver transplantation (cHLTx) remains uncommon in the United States and criteria for cHLTx are unclear. The objective of this study…”
    Get full text
    Journal Article
  13. 13

    Atypical Infiltrates on Endomyocardial Biopsy are Associated with Adverse Outcomes in Pediatric Heart Transplantation by Hope, K.D., Choudhry, S., Puri, K., Spinner, J.A., Tunuguntla, H.P., Price, J.F., Morris, S.A., Dreyer, W.J., Kearney, D.L., Denfield, S.W.

    “…The significance of atypical infiltrates, defined as eosinophils or plasma cells on endomyocardial biopsy (EMB) after pediatric heart transplant (HTx) is not…”
    Get full text
    Journal Article